COVID-19 trials registries data warehouse

 Return to trial list

Trial - EUCTR2020-001929-31-ES


Column Value
Trial registration number EUCTR2020-001929-31-ES
Full text link
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

First author
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Fundación Investigación Biomédica Hospital Ramón y Cajal - Anabel Sánchez

Contact
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

anabelsanchez.hrc@gmail.com

Registration date
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

2020-07-22

Recruitment status
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Recruiting

Study design
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

RCT

Allocation
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Randomized

Design
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Parallel

Masking
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Open label

Center
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

single-center

Study aim
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Treatment

Inclusion criteria
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

- Adult patients >18 years old - Confirmed diagnosis of COVID-19 or high clinical suspicion according to current criteria. - Previous diagnosis of DM2. - Patients who provide their informed consent to participate in the study - Pacientes adultos >18 años - Diagnóstico confirmado de COVID-19 o alta sospecha clínica según criterios actuales. - Diagnóstico previo al ingreso de DM2 . - Pacientes que faciliten su Consentimiento informado para participar en el estudio

Exclusion criteria
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

- Patients under 18 years - Known hypersensitivity to the active substance or any of the excipients of the drug. - Known history of heart failure or situation at the time of initiation of the cardiac failure study. - Liver failure. - Dialysis - Situation of diabetic ketoacidosis at the time of the start of the study. - Diabetes mellitus other than type 2. - Active bladder cancer or a history of bladder cancer - Non-philated macroscopic hematuria - Patients included in another experimental study with another drug. - Entry into the Intensive Care Unit. - Patients with mechanical ventilation requirement at the time of inclusion. - Pregnancy - Breastfeeding - Menores de 18 años - Hipersensibilidad conocida al principio activo o alguno de los excipientes del fármaco. - Antecedentes conocidos de insuficiencia cardiaca o situación en el momento del inicio del estudio de fallo cardiaco. - Insuficiencia hepática. - Diálisis - Situación de cetoacidosis diabética en el momento del inicio del estudio. - Diabetes mellitus diferente al tipo 2. - Cáncer de vejiga activo o antecedentes de cáncer de vejiga - Hematuria macroscópica no filiada - Pacientes incluidos en otro estudio experimental con otro fármaco. - Ingreso en Unidad de Cuidados Intensivos. - Pacientes con requerimiento de ventilación mecánica en el momento de la inclusión. - Embarazo - Lactancia

Number of arms
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

2

Funding
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Fundación Investigación Biomédica Hospital Ramón y Cajal

Inclusion age min
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

18

Inclusion age max
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

100

Countries
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Spain

Type of patients
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

No restriction on type of patients

Severity scale
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

0: No restriction on type of patients

Total sample size
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

76

primary outcome
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Outcome of the hospitalization (duration, discharge, need for mechanical ventilation, entry into UCI or Exitus). Safety: Rate of patients who develop heart failure or adverse reaction associated with the treatment Registro de duración y desenlace del ingreso en planta (duración ingreso, alta, necesidad de ventilación mecánica, ingreso en UCI o Exitus). Seguridad: Proporción de pacientes que desarrollan insuficiencia cardiaca o reacción adversa asociada al tratamiento.

Notes
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Declared number of arm (2.0) differs from found arms (1.0)

Phase
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Phase 4

Arms
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

[{"arm_notes": "", "treatment_id": 993, "treatment_name": "Pioglitazone", "treatment_type": "Metabolic agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]